Series B - Alebund Pharmaceuticals - Sep 13, 2021 Funding Round Profile - Cointime

Bitcoin $62,070.81 +2.34%
Ethereum $2,412.48 -0.23%
BNB $554.14 +0.26%
Optimism $1.56 +0.95%
Arbitrum $0.54 +0.97%
Solana $136.35 -0.64%
Polygon $0.39 +2.70%
Cosmos $4.24 +1.23%
Avalanche $24.74 -0.43%

Bitcoin $62,070.81 +2.34%
Ethereum $2,412.48 -0.23%
BNB $554.14 +0.26%
Optimism $1.56 +0.95%
Arbitrum $0.54 +0.97%
Solana $136.35 -0.64%
Polygon $0.39 +2.70%
Cosmos $4.24 +1.23%
Avalanche $24.74 -0.43%

Alebund Pharmaceuticals

company

Funding Round

Series B

Money Raised

$ 54.50M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Lilly Asia Ventures	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
May 9, 2021	Series B	$ 60M	Lilly Asia Ventures	Detail
Jan 1, 2020	Series A	0	Lilly Asia Ventures	Detail